Please ensure Javascript is enabled for purposes of website accessibility

Why Teladoc and Livongo Stocks Jumped Today

By Daniel Sparks – Sep 22, 2020 at 4:29PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The telehealth companies have a rosy future, according to one analyst.

What happened

Shares of Teladoc Health (TDOC -6.99%) and Livongo Health (LVGO), two telehealth companies that recently agreed to merge, rose sharply on Tuesday. By the time the market closed, the two stocks were up 6.3% and 5.9%, respectively.

The stocks' move higher was likely fueled by a combination of an overall bullish trading day for tech stocks and an analyst's decision to initiate coverage of Teladoc stock with a buy rating.

A chart showing stock prices moving higher

Image source: Getty Images.

So what

D.A. Davidson analyst Hannah Baade initiated coverage of Teladoc with a buy rating and a $250 12-month price target. The price target represents 16% upside -- and that's on top of the stock's more than 6% gain today.

Backing up her optimism for the stock, Baade notes that utilization rates of telehealth solutions are soaring. This secular tailwind, combined with the company's staggering organic growth and market-expanding acquisitions, make Teladoc Health a good investment, she argues.

Of course, given Teladoc's pending merger with Livongo, the two stocks mostly move in lockstep.

Now what

In a Sep. 16 update from Teladoc on the two companies' pending merger, Teladoc management said the transaction was on track to close by the end of the fourth quarter. Of course, there's always a risk that the deal could fall through.

Baade notably believes Teladoc provided conservative third-quarter guidance, setting the stage for actual results during the period to beat the consensus analyst estimate. Management guided for total third-quarter revenue to be between $275 million and $285 million. This compares to revenue of $138 million in the third quarter of 2019. Teladoc's top-line year-over-year comparison will benefit from the company's recent acquisition of InTouch Health, which closed on July 1.

Daniel Sparks owns shares of Livongo Health Inc. The Motley Fool owns shares of and recommends Livongo Health Inc and Teladoc Health. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Teladoc Health, Inc. Stock Quote
Teladoc Health, Inc.
$26.23 (-6.99%) $-1.97
Livongo Health, Inc. Stock Quote
Livongo Health, Inc.

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 09/30/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.